Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,700 people and operates in 12 countries. Learn more at mirion.com.

For investor inquiries, please contact: Jerry Estes ir@mirion.com

Grafico Azioni Mirion Technologies (NYSE:MIR)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Mirion Technologies
Grafico Azioni Mirion Technologies (NYSE:MIR)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Mirion Technologies